Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is 

Event Details

Q4 2019 Agios Pharmaceuticals Inc Earnings Conference Call

Feb 13, 2020 at 8:00 AM EST

Webcast Presentation

Title
Q4 2019 Agios Pharmaceuticals Inc Earnings Conference Call
Date / Time
Feb 13, 2020 at 8:00 AM EST